adamantane has been researched along with mocetinostat in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, J; Jaensch, H; Janda, I; Wood, WG | 1 |
| Aerts, JM; Boon, L; Bullens, D; Ceuppens, JL; Geboes, K; Kasran, A; Maerten, P; Rutgeerts, P; Shen, C; Van Assche, G | 1 |
| Fitzpatrick, LR; Green, CL; Maines, LW; Smith, CD; Zhuang, Y | 1 |
| Hu, Z; Tang, Z; Wang, Z; Zhai, W; Zhang, M | 1 |
| Abdel Ghafar, MT; Atlam, R; Elsaadany, A; Eshra, KA; Rizk, FH; Shaaban, AE; Shalaby, MM; Soliman, NA | 1 |
| Abd El Fattah, MA; Abdallah, DM; El-Abhar, HS; Kamel, NM | 1 |
| Abd Elhameed, AG; Helal, MG; Megahed, NA | 1 |
1 trial(s) available for adamantane and mocetinostat
| Article | Year |
|---|---|
Vildagliptin Recruits Regulatory T Cells in Patients Undergoing Primary Percutaneous Coronary Intervention.
Topics: Adamantane; C-Reactive Protein; CD4 Lymphocyte Count; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Interferon-gamma; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Nitric Oxide; Nitriles; Percutaneous Coronary Intervention; Peroxidase; Pyrrolidines; Serum Albumin; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1; Vildagliptin | 2018 |
6 other study(ies) available for adamantane and mocetinostat
| Article | Year |
|---|---|
A comparison of four immunometric assays for myeloperoxidase using luminescent and colorimetric signal detection.
Topics: Adamantane; Alkaline Phosphatase; Animals; Cattle; Colorimetry; Immunoassay; Immunoenzyme Techniques; Iodobenzenes; Luminescent Measurements; Luminol; Microchemistry; Nitrophenols; Organophosphorus Compounds; Peroxidase; Peroxides; Phthalazines; Polystyrenes; Reference Values | 1990 |
Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Anti-Inflammatory Agents; Antibodies; Body Weight; Colitis; Colon; Disease Models, Animal; Enzyme Inhibitors; Glycolipids; Haptens; Immunoglobulin G; Immunosuppressive Agents; Interferon-gamma; Interleukin-18; Male; Mice; Mice, Inbred C57BL; Oxazolone; Peroxidase; Trinitrobenzenesulfonic Acid | 2004 |
Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.
Topics: Adamantane; Aminosalicylic Acids; Animals; Body Weight; Colon; Crohn Disease; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Epithelial Cells; Female; Gastrointestinal Agents; Humans; Interleukin-1beta; Leukocytes; Male; Mice; Mice, Inbred C57BL; Neutrophils; Peroxidase; Phosphotransferases (Alcohol Group Acceptor); Prednisolone; Pyridines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2010 |
Profiling Proteinic Changes Induced by Vildagliptin Treatment in a Mouse Lung Transplantation Model: The Role of Kininogen-1.
Topics: Adamantane; Animals; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Down-Regulation; Immunohistochemistry; Kininogens; Lung; Lung Transplantation; Male; Mice; Nitriles; Peroxidase; Pyrrolidines; Up-Regulation; Vildagliptin | 2017 |
Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways.
Topics: Adamantane; Animals; Atrial Natriuretic Factor; Cell Adhesion Molecules; Chemokine CXCL12; Cyclic AMP; Dipeptides; Disease Models, Animal; Glucagon-Like Peptide 1; Glutathione; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Male; Malondialdehyde; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Receptors, CXCR4; Reperfusion Injury; Signal Transduction; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A | 2019 |
Saxagliptin mitigates airway inflammation in a mouse model of acute asthma via modulation of NF-kB and TLR4.
Topics: Acute Disease; Adamantane; Animals; Asthma; Bronchoalveolar Lavage Fluid; Dexamethasone; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; L-Lactate Dehydrogenase; Lung; Male; Mice; NF-kappa B; Nitric Oxide; Ovalbumin; Peroxidase; Toll-Like Receptor 4 | 2019 |